JP2024519188A5 - - Google Patents
Info
- Publication number
- JP2024519188A5 JP2024519188A5 JP2024515728A JP2024515728A JP2024519188A5 JP 2024519188 A5 JP2024519188 A5 JP 2024519188A5 JP 2024515728 A JP2024515728 A JP 2024515728A JP 2024515728 A JP2024515728 A JP 2024515728A JP 2024519188 A5 JP2024519188 A5 JP 2024519188A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- groups
- cancer
- general formula
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110565410 | 2021-05-24 | ||
| CN202110565410.0 | 2021-05-24 | ||
| CN202110694022 | 2021-06-22 | ||
| CN202110694022.2 | 2021-06-22 | ||
| CN202110856289.7 | 2021-07-28 | ||
| CN202110856289 | 2021-07-28 | ||
| CN202210198679.4 | 2022-03-02 | ||
| CN202210198679 | 2022-03-02 | ||
| PCT/CN2022/094612 WO2022247816A1 (zh) | 2021-05-24 | 2022-05-24 | 含氮杂环类化合物、其制备方法及其在医药上的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519188A JP2024519188A (ja) | 2024-05-08 |
| JP2024519188A5 true JP2024519188A5 (cg-RX-API-DMAC7.html) | 2025-06-03 |
Family
ID=84229501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515728A Pending JP2024519188A (ja) | 2021-05-24 | 2022-05-24 | 含窒素複素環系化合物、その調製方法及びその医薬的応用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240287094A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4349836A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024519188A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240012437A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117177971A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022280845A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023022496A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219858A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023013890A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI926045B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022247816A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI876212B (zh) | 2021-10-01 | 2025-03-11 | 美商辛瑟拉股份有限公司 | 吖丁啶及吡咯啶parp1抑制劑及其用途 |
| CN120081844A (zh) | 2022-01-21 | 2025-06-03 | 新特拉有限公司 | Parp1抑制剂及其用途 |
| US20250214980A1 (en) | 2022-03-14 | 2025-07-03 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| PT4497438T (pt) | 2022-04-28 | 2025-10-31 | Xinthera Inc C/O Gilead Sciences Inc | Inibidores tricíclicos da parp1 e suas utilizações |
| EP4524142A4 (en) * | 2022-05-07 | 2026-07-01 | Scibrunch Therapeutics Co Ltd | FLUOROQUINOXALINONE DERIVATIVE FOR THE SELECTIVE INHIBITION OF PARP1 |
| WO2024041643A1 (zh) * | 2022-08-25 | 2024-02-29 | 江苏恒瑞医药股份有限公司 | 稠合三环类化合物、其制备方法及其在医药上的应用 |
| KR20250103773A (ko) * | 2022-11-23 | 2025-07-07 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 질소 함유 헤테로시클릭계 화합물의 약학적으로 사용 가능한 염, 결정형 및 제조 방법 |
| AU2023412594A1 (en) * | 2022-12-23 | 2025-07-10 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Parp1 inhibitors |
| JP2026524090A (ja) | 2023-06-08 | 2026-07-17 | 上海森▲輝▼医▲葯▼有限公司 | ホルムアミド系化合物の製造方法 |
| CN120677162A (zh) * | 2023-06-13 | 2025-09-19 | 中国医药研究开发中心有限公司 | 含氮杂环类化合物及其医药用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138564A (en) * | 1977-08-03 | 1979-02-06 | American Home Products Corporation | Tetrahydro[1H]pyrazino[1,2-a]azaquinoxalin-5(6H)-ones and derivatives thereof |
| AUPS137402A0 (en) * | 2002-03-26 | 2002-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Novel tricyclic compounds |
| JP5545955B2 (ja) | 2007-03-08 | 2014-07-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Parpおよびtank阻害剤としてのキノリノン誘導体 |
| WO2009053373A1 (en) | 2007-10-26 | 2009-04-30 | Janssen Pharmaceutica Nv | Quinolinone derivatives as parp inhibitors |
| CN102372716A (zh) * | 2010-08-09 | 2012-03-14 | 江苏恒瑞医药股份有限公司 | 酞嗪酮类衍生物、其制备方法及其在医药上的应用 |
| TWI693218B (zh) | 2014-11-14 | 2020-05-11 | 美商美國禮來大藥廠 | 極光a激酶抑制劑 |
| WO2020098774A1 (zh) * | 2018-11-16 | 2020-05-22 | 江苏恒瑞医药股份有限公司 | 一种包含parp抑制剂的药物组合物 |
| TWI837403B (zh) * | 2019-07-19 | 2024-04-01 | 瑞典商阿斯特捷利康公司 | 化學化合物 |
| CN116018132A (zh) | 2020-06-24 | 2023-04-25 | Itf研究制药有限公司 | 软明胶胶囊 |
| US11795158B2 (en) | 2020-06-25 | 2023-10-24 | Astrazeneca Ab | Chemical compounds |
| TW202309025A (zh) * | 2021-04-19 | 2023-03-01 | 美商辛瑟拉股份有限公司 | Parp1抑制劑及其用途 |
| EP4524142A4 (en) * | 2022-05-07 | 2026-07-01 | Scibrunch Therapeutics Co Ltd | FLUOROQUINOXALINONE DERIVATIVE FOR THE SELECTIVE INHIBITION OF PARP1 |
-
2022
- 2022-05-24 AU AU2022280845A patent/AU2022280845A1/en active Pending
- 2022-05-24 EP EP22810541.7A patent/EP4349836A4/en active Pending
- 2022-05-24 US US18/562,127 patent/US20240287094A1/en active Pending
- 2022-05-24 CN CN202280027629.8A patent/CN117177971A/zh active Pending
- 2022-05-24 TW TW111119308A patent/TWI926045B/zh active
- 2022-05-24 WO PCT/CN2022/094612 patent/WO2022247816A1/zh not_active Ceased
- 2022-05-24 JP JP2024515728A patent/JP2024519188A/ja active Pending
- 2022-05-24 KR KR1020237042926A patent/KR20240012437A/ko active Pending
- 2022-05-24 BR BR112023022496A patent/BR112023022496A2/pt unknown
- 2022-05-24 MX MX2023013890A patent/MX2023013890A/es unknown
- 2022-05-24 CA CA3219858A patent/CA3219858A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111295384A (zh) | 双环类衍生物抑制剂、其制备方法和应用 | |
| JP2024522766A5 (cg-RX-API-DMAC7.html) | ||
| US11878000B2 (en) | Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors | |
| CN111989332A (zh) | 作为cdk抑制剂的大环化合物、其制备方法及其在医药上的应用 | |
| JP2019535720A5 (cg-RX-API-DMAC7.html) | ||
| JP2014503574A5 (cg-RX-API-DMAC7.html) | ||
| RU2020102453A (ru) | Фармацевтические композиции | |
| JP2019529444A5 (cg-RX-API-DMAC7.html) | ||
| IL319292A (en) | Cytotoxic imidazo[2,1-A]pyridine compounds and their use in therapy | |
| JP2023530456A5 (cg-RX-API-DMAC7.html) | ||
| JP2019509986A (ja) | トリプトライドのグルコース・コンジュゲート、その類縁体及び使用 | |
| US20250154098A1 (en) | Substituted bisphenylalkylurea compounds and methods of treating breast cancer | |
| JP2020503376A5 (cg-RX-API-DMAC7.html) | ||
| JP2017503753A5 (cg-RX-API-DMAC7.html) | ||
| EP2144887A1 (en) | Dosages and methods for the treatment of cancer | |
| JP2025111532A (ja) | 5-ブロモピリジン-3-イル-3-デオキシ-3-[4-(3,4,5-トリフルオロフェニル)-1h-1,2,3-トリアゾール-1-yl]-1-チオ-アルファ-d-ガラクトピラノシド及びその結晶形を調製するための大規模方法 | |
| EP4591940A3 (en) | Deoxy- cytidine derivatives for use in cancer therapies | |
| JP2005531563A5 (cg-RX-API-DMAC7.html) | ||
| JP2018140987A5 (cg-RX-API-DMAC7.html) | ||
| US20160102066A1 (en) | Benzothiazole derivative and anti-tumor use thereof | |
| US20160102095A1 (en) | Pyrazolo[1,5-a]pyrimidine derivative and use of anti-tumor thereof | |
| KR102138415B1 (ko) | 신규 peg 유도체 | |
| JP4267447B2 (ja) | 細胞増殖抑制作用を有するランタン化合物 | |
| US20240140947A1 (en) | Compound for the treatment of cancer | |
| Geleverya et al. | Synthesis of new 4, 4’-(1H-1, 2, 3-triazole)-bis (1H-pyrazol-5-ols) and prospects for their study as potential antitumor agent |